Personal information

Other IDs

ResearcherID: V-5413-2018

Countries

Netherlands

Activities

Collapse all

Employment (4)

Leiden University Medical Center: Leiden, NL

2018-01-01 to present | Resident (AIOS KO) (Internal Medicine)
Employment
Source: Self-asserted source
Marie-Astrid Hoogerwerf

Leids Universitair Medisch Centrum: Leiden, Zuid-Holland, NL

2017-01-01 to present | PhD Student (Parasitology/Infectious Disease)
Employment
Source: Self-asserted source
Marie-Astrid Hoogerwerf

Haaglanden Medisch Centrum: The Hague, NL

2015-01-01 to 2017-12-31 | Resident Internal Medicine (AIOS) (Internal Medicine)
Employment
Source: Self-asserted source
Marie-Astrid Hoogerwerf

Haaglanden Medisch Centrum: The Hague, NL

2014-02-01 to 2014-12-31 | Intern (ANIOS: arts niet in opleiding tot specialist) (Internal Medicine)
Employment
Source: Self-asserted source
Marie-Astrid Hoogerwerf

Education and qualifications (2)

Universiteit Leiden: Leiden, Zuid-Holland, NL

2010-09-01 to 2013-12-20 | MD, with honours (Faculty of Medicine)
Education
Source: Self-asserted source
Marie-Astrid Hoogerwerf

Universiteit Leiden: Leiden, Zuid-Holland, NL

2007-09-01 to 2010-06 | BSc (Faculty of Medicine)
Education
Source: Self-asserted source
Marie-Astrid Hoogerwerf

Works (12)

Safety, Tolerability, and Immunogenicity of the Invaplex<sub>AR-Detox</sub> <i>Shigella</i> Vaccine Co-Administered with the dmLT Adjuvant in Dutch and Zambian Adults: Study Protocol for a Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Phase Ia/b Clinical Trial

Vaccines
2025-01 | Journal article | Author
DOI: 10.3390/vaccines13010048
Contributors: Geert V.T. Roozen; Nsofwa Sukwa; Masuzyo Chirwa; Jessica A. White; Marcus Estrada; Nicole Maier; K. Ross Turbyfill; Renee Laird; Akamol E. Suvarnapunya; Aicha Sayeh et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

What motivates SARS-CoV-2 vaccine trial participants? A pre- and post-participation survey study

Trials
2024-11-06 | Journal article
DOI: 10.1186/s13063-024-08582-z
Contributors: Olivia A. C. Lamers; Meta Roestenberg; Martine C. de Vries; Marie-Astrid Hoogerwerf
Source: check_circle
Crossref

Controlled human hookworm infection remodels plasmacytoid dendritic cells and regulatory T cells towards profiles seen in natural infections in endemic areas

Nature Communications
2024-07-16 | Journal article
DOI: 10.1038/s41467-024-50313-0
Contributors: Mikhael D. Manurung; Friederike Sonnet; Marie-Astrid Hoogerwerf; Jacqueline J. Janse; Yvonne Kruize; Laura de Bes-Roeleveld; Marion König; Alex Loukas; Benjamin G. Dewals; Taniawati Supali et al.
Source: check_circle
Crossref

Early symptom-associated inflammatory responses shift to type 2 responses in controlled human schistosome infection

Science Immunology
2024-07-05 | Journal article
DOI: 10.1126/sciimmunol.adl1965
Contributors: Emma L. Houlder; Koen A. Stam; Jan Pieter R. Koopman; Marion H. König; Marijke C. C. Langenberg; Marie-Astrid Hoogerwerf; Paula Niewold; Friederike Sonnet; Jacqueline J. Janse; Miriam Casacuberta Partal et al.
Source: check_circle
Crossref

Changes in pro inflammatory and regulatory immune responses during controlled human schistosome infection and the development of clinical symptoms

2023-09-04 | Preprint
DOI: 10.1101/2023.09.01.23294933
Contributors: Emma L. Houlder; Koen A. Stam; Jan Pieter R. Koopman; Marion H. König; Marijke C.C. Langenberg; Marie-Astrid Hoogerwerf; Paula Niewold; Friederike Sonnet; Jacqueline J. Janse; Miriam Casacuberta Partal et al.
Source: check_circle
Crossref

A Randomized Controlled Trial to Investigate Safety and Variability of Egg Excretion After Repeated Controlled Human Hookworm Infection

The Journal of Infectious Diseases
2021-03-03 | Journal article
DOI: 10.1093/infdis/jiaa414
Contributors: Marie-Astrid Hoogerwerf; Jan Pieter R Koopman; Jacqueline J Janse; Marijke C C Langenberg; Roos van Schuijlenburg; Yvonne C M Kruize; Eric A T Brienen; Mikhael D Manurung; Petra Verbeek-Menken; Martha T van der Beek et al.
Source: check_circle
Crossref

The ethics of deferred consent in times of pandemics

Nature Medicine
2020-09 | Journal article
DOI: 10.1038/s41591-020-0999-9
Contributors: Rieke van der Graaf; Marie-Astrid Hoogerwerf; Martine C. de Vries
Source: check_circle
Crossref

Money-oriented risk-takers or deliberate decision-makers: a cross-sectional survey study of participants in controlled human infection trials

BMJ Open
2020-07 | Journal article
DOI: 10.1136/bmjopen-2019-033796
Contributors: Marie-Astrid Hoogerwerf; Martine de Vries; Meta Roestenberg
Source: check_circle
Crossref

A double-blind, placebo-controlled phase 1/2a trial of the genetically attenuated malaria vaccine PfSPZ-GA1

Science Translational Medicine
2020-05-20 | Journal article
DOI: 10.1126/scitranslmed.aaz5629
Contributors: Meta Roestenberg; Jona Walk; Saskia C. van der Boor; Marijke C. C. Langenberg; Marie-Astrid Hoogerwerf; Jacqueline J. Janse; Mikhael Manurung; X. Zen Yap; Amanda Fabra García; Jan Pieter R. Koopman et al.
Source: check_circle
Crossref

New insights into the kinetics and variability of egg excretion in controlled human hookworm infections.

The Journal of infectious diseases
2019-05-11 | Journal article
DOI: 10.1093/infdis/jiz218
PMID: 31077279
Source: Self-asserted source
Marie-Astrid Hoogerwerf
grade
Preferred source (of 2)‎

Katayama Syndrome Without Schistosoma mansoni Eggs.

Annals of internal medicine
2019-01-08 | Journal article
DOI: 10.7326/l18-0438
PMID: 30615787
Source: Self-asserted source
Marie-Astrid Hoogerwerf

Experimental infection of human volunteers

Lancet Infect Dis
2018 | Journal article
DOI: 10.1016/s1473-3099(18)30177-4
Source: Self-asserted source
Marie-Astrid Hoogerwerf

Peer review (4 reviews for 1 publication/grant)

Review activity for PLoS neglected tropical diseases (4)
How many people are using ORCID?